Medicare Enrolled
Dr. Douglas Lyle, M.D.
Cardiovascular Disease · Laguna Hills, CA
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lyle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lyle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lyle
Dr. Douglas Lyle is a cardiovascular disease specialist in Laguna Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lyle performed 972 Medicare services across 622 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lyle received a total of $12,419 from 44 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lyle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 972 Medicare services
$12,419 industry payments
Medicare Practice Summary
Medicare Utilization ↗972
Medicare services
Bottom 32% in CA for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
622
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
187 | $98 | $150 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
182 | $21 | $38 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
125 | $11 | $26 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
66 | $25 | $40 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
64 | $46 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $79 | $111 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
45 | $42 | $87 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
45 | $20 | $60 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
45 | $203 | $338 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
44 | $178 | $266 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
32 | $102 | $150 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
20 | $18 | $40 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
20 | $786 | $1,100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
16 | $410 | $594 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
16 | $60 | $120 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
14 | $65 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.4% high complexity
22.4% medium
60.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,419
Total received (2018-2024)
Avg $1,774/year across 7 years
Top 24% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
438
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,097 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$322 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$391
2023
$646
2022
$1,890
2021
$2,632
2020
$1,419
2019
$2,929
2018
$2,512
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$157
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$51
Novo Nordisk Inc
$36
Inari Medical, Inc.
$28
Alnylam Pharmaceuticals Inc.
$25
SCPHARMACEUTICALS INC.
$22
Boston Scientific Corporation
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
SANOFI-AVENTIS U.S. LLC
$16
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 62.5% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$3,927
Amgen Inc.
$1,050
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$658
Janssen Pharmaceuticals, Inc
$634
SANOFI-AVENTIS U.S. LLC
$611
Astellas Pharma US Inc
$566
PFIZER INC.
$456
Regeneron Healthcare Solutions, Inc.
$414
Abbott Laboratories
$404
Amarin Pharma Inc.
$395
Esperion Therapeutics, Inc.
$368
CVRx, Inc.
$276
Novo Nordisk Inc
$254
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Boston Scientific Corporation
$234
E.R. Squibb & Sons, L.L.C.
$200
Novartis Pharmaceuticals Corporation
$199
Merck Sharp & Dohme LLC
$166
Medtronic Vascular, Inc.
$137
Acutus Medical, Inc.
$127
Gilead Sciences, Inc.
$125
Otsuka America Pharmaceutical, Inc.
$119
Inari Medical, Inc.
$115
Bayer HealthCare Pharmaceuticals Inc.
$112
Alnylam Pharmaceuticals Inc.
$77
Tactile Systems Technology Inc
$53
ARBOR PHARMACEUTICALS, INC.
$50
Cardinal Health 200, LLC
$48
ABIOMED
$43
SCPHARMACEUTICALS INC.
$43
Kiniksa Pharmaceuticals, Ltd.
$37
MEDICOMP INC
$33
BOSTON SCIENTIFIC CORPORATION
$33
Impulse Dynamics (USA) Inc.
$29
Cardiovascular Systems Inc.
$25
Allergan Inc.
$25
AstraZeneca Pharmaceuticals LP
$23
Celgene Corporation
$23
Preventice Services, LLC
$21
Merck Sharp & Dohme Corporation
$18
HeartFlow, Inc.
$15
Itamar Medical Inc
$14
Medtronic, Inc.
$12
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AMVUTTRA · Acticor · Acticor 7 VR-T DX · BG Mini Plus · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · Cardiac Monitor · CardioMEMS HF System · Carnation Ambulatory Monitor · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edora · Edora 8 DR-T · FLEXITOUCH · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL TACHY · HeartWare HVAD · Impella · JARDIANCE · JOT DX · Kerendia · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPTIMIZER · Ozempic · PK Papyrus · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S · SAMSCA · Solia · Tryton Side Branch Stent · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WatchPAT · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
192
Per 100K population
6.1
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lyle is a remote & cardiac specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lyle experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lyle performed 187 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lyle receive payments from pharmaceutical companies?
Yes. Dr. Lyle received a total of $12,419 from 44 companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lyle's costs compare to other cardiologists in Laguna Hills?
Dr. Lyle's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lyle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Laguna Hills
Browse cardiologists in Laguna Hills ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology